Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Business Divestiture
SOLV logo

Solventum Nets $1.5B Gain from $4B Divestiture

SOLV10-QFiling Date: 11/7/2025
Solventum Corporation
Description

What this story covers

Solventum's Q3 2025 10-Q highlights a 4 billion dollar Purification sale yielding 1 point 5 billion dollar gain, boosting net income to 1 point 27 billion dollars. Core sales grew modestly at 2 point 4 percent year-to-date, with focus on MedSurg, Dental, and Health IT segments. Debt reduced, liquidity strong for 500 million dollar savings initiative amid stable risks.

Story snapshot

CompanySolventum Corporation
TickerSOLV
VariantStandard detailed
Duration13:46
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001964738-25-000091

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in